-
Dec.202017NEWS
HanAll Biopharma has successfully transferred the technology of new antibody drug for autoimmune disease to a foreign company
HanAll Biopharma has successfully transferred the technology of new antibody drug for autoimmune dis..
-
Oct.192017NEWS
HanAll Biopharma and Harbour BioMed Sign Collaboration and License Agreement to Develop Two Novel Biologic Therapies in Greater China
HanAll Biopharma and Harbour BioMed Sign Collaboration and License Agreement to Develop Two Novel Bi..
-
Nov.192015NEWS
HanAll Biopharma, Approved for Clinical Trial Phase 1 of HL036, New Medicine for Dry Eye Disease
HanAll Biopharma, Approved for Clinical Trial Phase 1 of HL036, New Medicine for Dry Eye Disease
-
Sep.302015NEWS
HanAll Biopharma Beginning of Zero Debt Firm with Full Repayment of Debt
HanAll Biopharma Beginning of Zero Debt Firm with Full Repayment of Debt
-
Sep.042015NEWS
HanAll Biopharma to Launch Tadalafil-containing Impotence Drug ‘‘Fordream Tab’
HanAll Biopharma to Launch Tadalafil-containing Impotence Drug ‘‘Fordream Tab’
-
Jun.012015NEWS
HanAll Biopharma Accelerates Global R&D through Joint Management with Daewoong Pharmaceutical
HanAll Biopharma Accelerates Global R&D through Joint Management with Daewoong Pharmaceutical